Paper Details

  1. Home
  2. Paper Details

Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.

Author: HeijtinkR A, KnolR M, SchalmS W

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Intramuscular and intradermal administration of low-dose hepatitis B vaccine were both effective in inducing protective immunity, with the intramuscular route being preferred due to ease of administration and avoidance of long-term side effects.
Paper Details　
Original Abstract of the Article :
In a randomized controlled trial, 165 healthy medical students were immunized either by the intramuscular route (IM group) or by the intradermal route (ID group) with low-dose (2 micrograms) plasma hepatitis B vaccine (HB-VAX) at months 0, 1, 2, and 6. At month 7, protective immunity (anti-HBs great...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/jmv.1890270216

データ提供：米国国立医学図書館（NLM）

Hepatitis B Vaccination: Finding the Right Path in the Desert of Immunity

Hepatitis B, like a hidden spring in the desert, can lurk undetected, posing a threat to health. This study examines the effectiveness of a low-dose hepatitis B vaccine, a precious resource in the desert of immunity. The study compares the immunogenicity of intramuscular (IM) and intradermal (ID) routes of administration, similar to exploring different pathways through a desert landscape. The findings indicate that both routes effectively induce protective immunity, offering a choice for individuals seeking protection from hepatitis B. The study highlights the importance of cost-effectiveness, emphasizing that the IM route may be more practical and affordable for young, healthy individuals.

Choosing the Right Path: IM vs. ID Vaccination

The study reveals that both IM and ID routes of administration for the low-dose hepatitis B vaccine effectively induce protective immunity. It's like discovering two paths through the desert, both leading to the same destination. The study provides valuable information for healthcare providers to make informed decisions about the best route of vaccination based on individual needs and circumstances. The study's emphasis on cost-effectiveness is particularly relevant, highlighting the importance of finding efficient solutions in the desert of limited resources.

Protecting Ourselves: The Importance of Vaccination

The study underscores the importance of vaccination in protecting individuals from the threat of hepatitis B, a silent danger lurking in the desert of our immune system. It reminds us that prevention is key, like carefully guarding a precious oasis from encroaching sandstorms. Regular vaccinations, guided by healthcare professionals, are essential for maintaining good health and preventing serious diseases.

Dr. Camel's Conclusion

This study provides valuable insights into the effectiveness of low-dose hepatitis B vaccination, offering a cost-effective and safe way to protect against this serious disease. It's a reminder that even in the vast and challenging desert of disease, we have the tools and knowledge to protect ourselves and others.

Date :
  1. Date Completed 1989-04-11
  2. Date Revised 2019-08-28
Further Info :

Pubmed ID

2522147

DOI: Digital Object Identifier

10.1002/jmv.1890270216

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.